A brain-boosting protein plays an important role in how well people respond to chemotherapy, according to a new study. The study detailed that cancer patients suffering from depression are less responsive to cancer drugs and less tolerant of their side-effects. Low mood is common among cancer patients, especially the terminally ill. A recent study aimed to discover how depression influenced outcomes for people with advanced lung cancer.
A scientist said that it is crucial for doctors to pay more attention to the mood and emotional status of patients. According to this study, depression can reduce the effects of chemotherapy and Brain-derived neurotrophic factor (BDNF) plays an important role in this process. BDNF is essential for healthy brain function and low levels have already been linked with mental illness. Results showed that patients whose cancer had metastasized to other organs…
